Memory CD8 T cells (TMEM) and exhausted CD8 T cells (TEX) are essential for host defense against infection and cancer, yet their therapeutic potential is often limited by insufficient persistence and sustained functional capacity. Strategies to enhance the longevity of both populations remain scarce. Here, we demonstrate that ablation of UBE2F, a neddylation E2 enzyme, induces a resilience program in CD8 T cells that operates across both TMEM and TEX compartments, resulting in improved viral and tumor control. This resilience state is characterized by enhanced self-renewal and survival without perturbing the conventional CD8 T cell differentiation trajectories. Mechanistically, UBE2F deficiency inhibited neddylation of CUL5, leading to accumulation of JUNB and upregulation of IL-2Rβ. The increased IL-2Rβ expression hypersensitizes CD8 T cells to physiological IL-15, thereby conferring the resilience features. Together, these findings identify the UBE2F–CUL5–JUNB–IL-2Rβ axis as a conserved posttranslational mechanism regulating CD8 T cell longevity across memory and exhausted states, providing a novel strategy for enhancing antiviral and antitumor immunity.
Article navigation
Article|
May 26 2026
Targeting UBE2F induces a resilience program enhancing CD8 T cell immunity
Xiaonan Ma
,
Xiaonan Ma
(Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing - review & editing)
1
State Key Laboratory of Molecular Oncology, Institute for Immunology, Beijing Key Laboratory for Mechanisms and Drug Development of Allergic Diseases, School of Basic Medical Sciences, Tsinghua Medicine, Tsinghua University
, Beijing, China
2
SXMU-Tsinghua Collaborative Innovation Center for Frontier Medicine, Shanxi Medical University
, Taiyuan, China
3
Tsinghua-Peking Center for Life Sciences
, Beijing, China
4
Peking University-Tsinghua University-National Institute of Biological Sciences Joint Graduate Program, Academy for Advanced Interdisciplinary Studies, Tsinghua University
, Beijing, China
Search for other works by this author on:
Henan Guo
,
Henan Guo
(Data curation, Formal analysis)
1
State Key Laboratory of Molecular Oncology, Institute for Immunology, Beijing Key Laboratory for Mechanisms and Drug Development of Allergic Diseases, School of Basic Medical Sciences, Tsinghua Medicine, Tsinghua University
, Beijing, China
2
SXMU-Tsinghua Collaborative Innovation Center for Frontier Medicine, Shanxi Medical University
, Taiyuan, China
3
Tsinghua-Peking Center for Life Sciences
, Beijing, China
Search for other works by this author on:
Yuting Jia
,
Yuting Jia
(Investigation, Methodology)
2
SXMU-Tsinghua Collaborative Innovation Center for Frontier Medicine, Shanxi Medical University
, Taiyuan, China
Search for other works by this author on:
Na Yin
,
Na Yin
(Formal analysis, Project administration)
1
State Key Laboratory of Molecular Oncology, Institute for Immunology, Beijing Key Laboratory for Mechanisms and Drug Development of Allergic Diseases, School of Basic Medical Sciences, Tsinghua Medicine, Tsinghua University
, Beijing, China
2
SXMU-Tsinghua Collaborative Innovation Center for Frontier Medicine, Shanxi Medical University
, Taiyuan, China
3
Tsinghua-Peking Center for Life Sciences
, Beijing, China
Search for other works by this author on:
Min Peng
(Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Visualization, Writing - original draft, Writing - review & editing)
1
State Key Laboratory of Molecular Oncology, Institute for Immunology, Beijing Key Laboratory for Mechanisms and Drug Development of Allergic Diseases, School of Basic Medical Sciences, Tsinghua Medicine, Tsinghua University
, Beijing, China
2
SXMU-Tsinghua Collaborative Innovation Center for Frontier Medicine, Shanxi Medical University
, Taiyuan, China
3
Tsinghua-Peking Center for Life Sciences
, Beijing, China
Correspondence to Min Peng: [email protected]
Search for other works by this author on:
Xiaonan Ma
https://orcid.org/0009-0009-7048-1966
Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing - review & editing
1
State Key Laboratory of Molecular Oncology, Institute for Immunology, Beijing Key Laboratory for Mechanisms and Drug Development of Allergic Diseases, School of Basic Medical Sciences, Tsinghua Medicine, Tsinghua University
, Beijing, China
2
SXMU-Tsinghua Collaborative Innovation Center for Frontier Medicine, Shanxi Medical University
, Taiyuan, China
3
Tsinghua-Peking Center for Life Sciences
, Beijing, China
4
Peking University-Tsinghua University-National Institute of Biological Sciences Joint Graduate Program, Academy for Advanced Interdisciplinary Studies, Tsinghua University
, Beijing, China
Henan Guo
https://orcid.org/0009-0006-0962-2887
Data curation, Formal analysis
1
State Key Laboratory of Molecular Oncology, Institute for Immunology, Beijing Key Laboratory for Mechanisms and Drug Development of Allergic Diseases, School of Basic Medical Sciences, Tsinghua Medicine, Tsinghua University
, Beijing, China
2
SXMU-Tsinghua Collaborative Innovation Center for Frontier Medicine, Shanxi Medical University
, Taiyuan, China
3
Tsinghua-Peking Center for Life Sciences
, Beijing, China
Yuting Jia
https://orcid.org/0009-0001-8110-0817
Investigation, Methodology
2
SXMU-Tsinghua Collaborative Innovation Center for Frontier Medicine, Shanxi Medical University
, Taiyuan, China
Na Yin
https://orcid.org/0000-0002-8280-6512
Formal analysis, Project administration
1
State Key Laboratory of Molecular Oncology, Institute for Immunology, Beijing Key Laboratory for Mechanisms and Drug Development of Allergic Diseases, School of Basic Medical Sciences, Tsinghua Medicine, Tsinghua University
, Beijing, China
2
SXMU-Tsinghua Collaborative Innovation Center for Frontier Medicine, Shanxi Medical University
, Taiyuan, China
3
Tsinghua-Peking Center for Life Sciences
, Beijing, China
Min Peng
https://orcid.org/0000-0002-5885-0660
Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Visualization, Writing - original draft, Writing - review & editing
1
State Key Laboratory of Molecular Oncology, Institute for Immunology, Beijing Key Laboratory for Mechanisms and Drug Development of Allergic Diseases, School of Basic Medical Sciences, Tsinghua Medicine, Tsinghua University
, Beijing, China
2
SXMU-Tsinghua Collaborative Innovation Center for Frontier Medicine, Shanxi Medical University
, Taiyuan, China
3
Tsinghua-Peking Center for Life Sciences
, Beijing, China
Correspondence to Min Peng: [email protected]
Disclosures: M. Peng reported a patent has been filed by Tsinghua University based on findings described in this study pending. No other disclosures were reported.
Received:
December 27 2025
Revision Received:
March 09 2026
Accepted:
April 21 2026
Online ISSN: 1540-9538
Print ISSN: 0022-1007
Funding
Funder(s):
National Natural Science Foundation of China
- Award Id(s): T2495270,82350108
Funder(s):
Tsinghua University
- Award Id(s): 52302102323
Funder(s):
Tsinghua-Peking Center for Life Sciences
Funder(s):
Shanxi Medical University-Tsinghua Collaborative Innovation Center for Frontier Medicine
© 2026 Ma et al.
2026
Ma et al.
This article is distributed under the terms as described at https://rupress.org/pages/terms102024/.
J Exp Med (2026) 223 (7): e20252687.
Article history
Received:
December 27 2025
Revision Received:
March 09 2026
Accepted:
April 21 2026
Citation
Xiaonan Ma, Henan Guo, Yuting Jia, Na Yin, Min Peng; Targeting UBE2F induces a resilience program enhancing CD8 T cell immunity. J Exp Med 6 July 2026; 223 (7): e20252687. doi: https://doi.org/10.1084/jem.20252687
Download citation file:
Sign in
Don't already have an account? Register
352
Views
Suggested Content
Email alerts
Advertisement
